Investor Overview

Stock Price

NASDAQ TCMD (Common Stock) $18.14 + 0.14
March 24, 20174:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Presentation

Download Documentation Q4 2016 Investor Presentation

Company Overview

Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. Headquartered in Minneapolis, Minnesota, we advocate for patient access and serve tens of thousands of patients through a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. Our products are proven to improve quality of life, increase clinical efficacy, and reduce overall healthcare costs.

Recent News

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results; Provides 2017 Outlook

February 27, 2017

Q4 Revenue Increased 35% Year-over-Year; Full Year 2016 Revenue Up 34% MINNEAPOLIS, Feb. 27, 2017 ... 

Read More >

Tactile Medical to Release Fourth Quarter and Fiscal Year 2016 Financial Results on February 27th

February 14, 2017

MINNEAPOLIS, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”... 

Read More >

Upcoming Events

There are currently no events scheduled.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet